SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shree Ganesh Remed. - Quaterly Results

15 May 2026 Evaluate
The sales surged to Rs. 331.96 millions, up 35.87% for the March 2026 quarter as against Rs. 244.32 millions during the corresponding quarter previous year.The Net Profit of the company registered a slight decline of -4.91% to Rs. 62.73  millions from Rs. 65.97 millions.OP of the company witnessed a marginal growth to 123.98 millions from 121.63 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 331.96 244.32 35.87 1092.86 1085.96 0.64 1092.86 1085.96 0.64
Other Income 10.23 22.87 -55.27 30.30 37.30 -18.77 30.30 37.30 -18.77
PBIDT 123.98 121.63 1.93 380.50 429.42 -11.39 380.50 429.42 -11.39
Interest 8.76 9.58 -8.56 35.62 20.77 71.50 35.62 20.77 71.50
PBDT 115.22 112.05 2.83 344.88 408.65 -15.61 344.88 408.65 -15.61
Depreciation 27.98 24.24 15.43 104.73 95.67 9.47 104.73 95.67 9.47
PBT 87.24 87.81 -0.65 240.15 312.98 -23.27 240.15 312.98 -23.27
TAX 24.51 21.84 12.23 62.42 81.99 -23.87 62.42 81.99 -23.87
Deferred Tax 9.78 -0.81 -1307.41 5.33 -0.45 -1284.44 5.33 -0.45 -1284.44
PAT 62.73 65.97 -4.91 177.73 230.99 -23.06 177.73 230.99 -23.06
Equity 128.38 128.38 0.00 128.38 128.38 0.00 128.38 128.38 0.00
PBIDTM(%) 37.35 49.78 -24.98 34.82 39.54 -11.95 34.82 39.54 -11.95

Shree Ganesh Remed. Share Price

587.35 27.65 (4.94%)
18-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.00
Dr. Reddys Lab 1267.80
Cipla 1355.80
Zydus Lifesciences 1074.30
Lupin 2327.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: